2025-04-09 - Analysis Report
## Procter & Gamble Co (PG) Stock Review

**0) Summary Statistics:**

Procter & Gamble Co (PG) is a consumer goods company producing and marketing a wide range of products.  The analysis below examines PG's performance against the S&P 500 (VOO), considering recent price movements, financial indicators, and earnings data.

**1) Performance Comparison with S&P 500 (VOO):**

PG's cumulative return (61.12%) significantly outperformed the S&P 500's cumulative return (55.84%) over the analyzed period. The difference is 5.28%, placing it at the 59.5th percentile of its historical range (max: 29.7%, min: -30.5%).  While this indicates relative outperformance, the historical context provided by the relative divergence is crucial for proper interpretation.

**Alpha and Beta Analysis:**

The provided alpha and beta values show mixed results across different time periods. While alpha is generally positive, indicating outperformance against the market, it's inconsistent and mostly small. Beta is consistently around 0.3, suggesting lower volatility than the overall market. The market capitalization has steadily increased.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 22.0% | 7.9% | -7.0% | 0.0 | 178.0 |
| 2016-2018  | 4.0% | 56.9% | -14.0% | 0.0 | 184.3 |
| 2017-2019  | 32.0% | 56.9% | 3.0% | 0.5 | 257.5 |
| 2018-2020  | 45.0% | 59.5% | 20.0% | 0.3 | 293.9 |
| 2019-2021  | 62.0% | 59.5% | 8.0% | 0.3 | 354.2 |
| 2020-2022  | 25.0% | 74.7% | 19.0% | 0.3 | 336.4 |
| 2021-2023  | 27.0% | 74.7% | 10.0% | 0.3 | 333.5 |
| 2022-2024  | 3.0% | 74.7% | -14.0% | 0.3 | 391.0 |
| 2023-2025  | -2.0% | 70.4% | -6.0% | 0.2 | 373.8 |


**2) Recent Price Movement:**

* **Closing Price:** 159.29
* **Last Market Price:** 159.61 (down $0.39 from previous close)
* **5-day MA:** 167.10
* **20-day MA:** 167.80
* **60-day MA:** 167.68

The current price is below all three moving averages, suggesting a downward trend.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4883 (High Risk)  Indicates a higher level of market volatility.
* **RSI:** 37.13 (Below 40, suggesting oversold conditions)
* **PPO:** -0.36 (Negative, indicating bearish momentum)
* **Recent Relative Strength Change:** +7.5 (Short-term upward momentum)


The negative price change combined with a high MRI, low RSI, and negative PPO suggests a bearish trend despite short term upward momentum.  The significant drop from the previous close warrants further investigation for potential news impacting the price.


**Expected Return:** 6.0%  This represents an expected outperformance relative to the S&P 500 over the long term (2+ years).

**4) Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|-------------|
| 2025-01-22 | 1.94  | $21.88 B     |
| 2024-10-18 | 1.65  | $21.74 B     |
| 2024-04-19 | 1.56  | $20.20 B     |
| 2024-01-23 | 1.44  | $21.44 B     |
| 2025-01-22 | 1.44  | $21.44 B     |

There's a noticeable jump in EPS and Revenue in the most recent quarter.  Further analysis is needed to determine the sustainability of this trend.  Note the duplicate entry for 2025-01-22 which may be an error.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $21.88B    | 52.39%        |
| 2024-09-30 | $21.74B    | 52.06%        |
| 2024-06-30 | $20.53B    | 49.60%        |
| 2024-03-31 | $20.20B    | 51.20%        |
| 2023-12-31 | $21.44B    | 52.69%        |

Revenue remains relatively stable, with slight fluctuations. Profit margins are consistently high, suggesting good operational efficiency.


**Capital and Profitability:**

| Quarter | Equity      | ROE     |
|---------|-------------|---------|
| 2024-12-31 | $51.17B    | 9.05%   |
| 2024-09-30 | $51.84B    | 7.64%   |
| 2024-06-30 | $50.29B    | 6.24%   |
| 2024-03-31 | $50.06B    | 7.50%   |
| 2023-12-31 | $48.53B    | 7.15%   |

Equity shows some fluctuation. ROE is generally healthy but has shown some recent variability.


**6) Overall Analysis:**

PG has shown strong historical outperformance against the S&P 500, although recent price action suggests a short-term bearish trend.  The high Market Risk Indicator warrants caution. While the fundamentals (high profit margins, relatively stable revenue) appear strong, the recent price drop and mixed technical indicators require further investigation before making any investment decisions.  The 6% expected long-term outperformance is promising, but only if the underlying issues driving the recent price decline are addressed.  Investors should monitor earnings reports, news, and market conditions closely.
